TG Therapeutics (TGTX) earnings

Earnings (net income) · fiscal 2025
$447.18M

TG Therapeutics (TGTX) reported net income of $447.18M in fiscal 2025 (the year ended December 31, 2025). That is 1812.4% higher than the $23.38M of fiscal 2024. Figures as of 18 Nov 2026, 07:35 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
$447.18M
Change on fiscal 2024
+1812.4%
Highest on record
$447.18Mfiscal 2025
Lowest on record
-$348.10Mfiscal 2021
Fiscal years on record
152011–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

TG Therapeutics earnings, in more detail

Across the 15 fiscal years on record (2011–2025), the highest was $447.18M in fiscal 2025 and the lowest -$348.10M in fiscal 2021.

History · 15 fiscal years

Earnings (net income) by fiscal year

TG Therapeutics earnings, year by year

TG Therapeutics (TGTX) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025$447.18M 1,812.4% up
2024$23.38M 84.5% up
2023$12.67M—
2022-$223.81M—
2021-$348.10M—
2020-$279.38M—
2019-$172.87M—
2018-$173.48M—
2017-$118.48M—
2016-$78.25M—
2015-$62.95M—
2014-$55.78M—
2013-$20.48M—
2012-$18.07M—
2011-$853.07K—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of TG Therapeutics and comparable companies
CompanyEarnings (net income)Fiscal year
Madrigal Pharmaceuticals MDGL-$288.28M2025
Henry Schein HSIC$398.00M2025
Oscar Health OSCR-$443.15M2025
TG Therapeutics TGTX$447.18M2025
Praxis Precision Medicines PRAX-$303.27M2025
Twist Bioscience TWST-$130.20M2026

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TGTX

TG Therapeutics, figure by figure

TG Therapeutics (TGTX) overview: price, valuation and scorecardAll health care companies by market value

TG Therapeutics earnings: questions and answers

What is TG Therapeutics's net income?

TG Therapeutics (TGTX) reported net income of $447.18M in fiscal 2025 (the year ended December 31, 2025). That is 1812.4% higher than the $23.38M of fiscal 2024.

What are the highest and lowest net income figures on record for TG Therapeutics?

Across the 15 fiscal years on record (2011–2025), the highest was $447.18M in fiscal 2025 and the lowest -$348.10M in fiscal 2021.

How is TG Therapeutics's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “TG Therapeutics (TGTX) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/TGTX/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.